Point72 Asset Management
MYOV

Point72 Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Point72 Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-154,800
Closed -$3.52M – 1294
2021
Q2 		$3.52M Buy
154,800
+116,400
+303% +$2.45M 0.02% 665
2021
Q1 		$790K Buy
+38,400
New +$874K ﹤0.01% 832
2019
Q4 		– Sell
-205,200
Closed -$1.07M – 1329
2019
Q3 		$1.07M Sell
205,200
-649,286
-76% -$4.82M 0.01% 680
2019
Q2 		$7.73M Buy
+854,486
New +$12.7M 0.04% 425
2017
Q4 		– Sell
-81,100
Closed -$1.25M – 1143
2017
Q3 		$1.25M Buy
+81,100
New +$986K 0.01% 720

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's MYOV Position: Q3 2021 in Review

Point72 Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2021, closing a stake of 154,800 shares — an estimated $3.52M sold.

Point72 Asset Management first reported a position in MYOV in Q3 2017 and held it in 5 quarters. The position peaked at $7.73M in Q2 2019. 105 funds tracked by Wall St. Rank hold MYOV as of Q3 2021.

  • Point72 Asset Management reported no remaining Myovant Sciences Ltd. position as of Q3 2021 after selling out during the quarter.
  • Point72 Asset Management sold 154,800 Myovant Sciences Ltd. shares in Q3 2021, an estimated $3.52M.
  • Point72 Asset Management first reported a position in Myovant Sciences Ltd. in Q3 2017 and held it in 5 quarters.
  • Point72 Asset Management's Myovant Sciences Ltd. position peaked at $7.73M in Q2 2019.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2021.

Based on Point72 Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.